Screening for pancreatic cancer in high-risk people
Part of Cancer clinical trials.
This study looks at people who are at higher risk for pancreatic cancer, such as those with a family history, certain gene changes, a pancreatic cyst, or new-onset diabetes. The goal is to find cancer early, when it may be easier to treat.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give your own consent to participate.
- You may qualify if you have a family history of pancreatic cancer.
- You may qualify if you carry a gene change that increases pancreatic cancer risk.
- You may qualify if you have a pancreatic cyst called IPMN.
- You may qualify if you have new-onset diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to screen the pancreas in people who are at increased risk for pancreatic cancer, using a set of risk guidelines. Screening may help find cancer (or early changes) sooner, when it may be easier to treat.
This trial uses MRI and endoscopic ultrasound to look for early signs of pancreatic cancer in people who have a high risk due to their genes or family history. Finding it early may lead to better treatment options.
This study screens people at high risk for pancreatic cancer using imaging tests. It aims to catch cancer early in those with certain genetic conditions or strong family history.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This study looks for people at high risk for pancreatic cancer, either because of family history, certain genetic mutations, or concerning pancreatic cysts. Researchers want to follow you over time to find cancer early, when it's easier to treat.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
Hear when a new Pancreas Cancer Screening trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.